Impact of PGE1 on cyclosporine A induced up-regulation of TGF-β1, its receptors, and related matrix production in cultured mesangial cells

被引:9
作者
Dell, K [1 ]
Böhler, T [1 ]
Gaedeke, J [1 ]
Budde, K [1 ]
Neumayer, HH [1 ]
Waiser, J [1 ]
机构
[1] Humboldt Univ, Hosp Charite, Dept Internal Med Nephrol, D-10117 Berlin, Germany
关键词
cyclosporine A; glomerulosclerosis; mesangial cells; prostaglandin E-1; transforming growth factor-beta;
D O I
10.1016/S1043-4666(03)00151-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-beta1 (TGF-beta1) plays a major role in cyclosporine A (CsA) induced glomerulosclerosis. We have recently shown that CsA up-regulates the expression of TGF-beta1 and its receptors type I (TbetaR-I) and type 11 (TbetaR-II) in rat mesangial cells (MCs). Prostaglandins of the E series (PGEs) are known to exert substantial anti-fibrotic effects. Here, we assessed the effect of PGE(1) on CsA induced up-regulation of TGF-beta1, TbetaR-I, TbetaR-II and related matrix production in MCs. Co-incubation with PGE(1) reduced CsA induced up-regulation of TGF-beta1 and TbetaR-II at the mRNA and protein level. Alike, PGE(1) reduced TbetaR-I protein expression, which is posttranscriptionally up-regulated by CsA. Whereas a low PGE1 concentration decreased CsA induced production of fibronectin (FN) and plasminogen activator inhibitor type-1 (PAI-1), a higher PGE(1) concentration did not change FN production, but further increased PAI-1 production. In vivo studies will show, whether treatment with PGE(1) analogues will be useful in preventing CsA induced glomerulosclerosis. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:189 / 193
页数:5
相关论文
共 15 条
  • [1] Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
    Bennett, WM
    DeMattos, A
    Meyer, MM
    Andoh, T
    Barry, JM
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (04) : 1089 - 1100
  • [2] RAT MESANGIAL CELLS PRODUCE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    BUDDE, K
    COLEMAN, DL
    LACY, J
    STERZEL, RB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (06): : F1065 - F1078
  • [3] THE EFFECT OF CYCLOSPORINE ON AGONIST-STIMULATED GLOMERULAR AND MESANGIAL CELL VASODILATORY PROSTAGLANDIN PRODUCTION
    BUNKE, M
    WILDER, L
    MARTIN, A
    [J]. TRANSPLANTATION, 1991, 52 (04) : 718 - 722
  • [4] The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival2
    Gjertson, DW
    Cecka, JM
    Terasaki, PI
    [J]. TRANSPLANTATION, 1995, 60 (12) : 1384 - 1388
  • [5] Transforming growth factor (TGF)-β mimics and anti-TGF-β antibody abrogates the in vivo effects of cyclosporine -: Demonstration of a direct role of TGF-β in immunosuppression and nephrotoxicity of cyclosporine
    Khanna, AK
    Cairns, VR
    Becker, CG
    Hosenpud, JD
    [J]. TRANSPLANTATION, 1999, 67 (06) : 882 - 889
  • [6] TGF-β:: A link between immunosuppression, nephrotoxicity, and CsA
    Khanna, AK
    Cairns, VR
    Becker, CG
    Hosenpud, JD
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 944 - 945
  • [7] MIHATSCH M, 1995, KIDNEY INT, V48, P63
  • [8] OPELZ G, 1992, TRANSPLANT P, V24, P2342
  • [9] Medical progress - Strategies to improve long-term outcomes after renal transplantation
    Pascual, M
    Theruvath, T
    Kawai, T
    Tolkoff-Rubin, N
    Cosimi, AB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) : 580 - 590
  • [10] Pricci F, 1996, DIABETOLOGIA, V39, P1055